Overview Financials News + Filings Key Docs Holdings Insiders
|
| In millions, except per share items | Mar-31-23 | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 |
| | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Dental | | 361.7 | | | | | |
| OperatingSegmentAll | | 4,585.1 | 3,107.5 | 3,030.9 | 2,782.2 | 2,620.0 | 2,612.8 |
| OperatingSegmentAllExceptCorpandOther | | 4,585.1 | 3,107.5 | 3,030.9 | 2,782.2 | 2,620.0 | 2,612.8 |
| Total revenues | 4,957.8 | 4,585.1 | 3,107.5 | 3,030.9 | 2,782.2 | 2,620.0 | 2,612.8 |
| Revenue growth [+] | 8.1% | 47.5% | 2.5% | 8.9% | 6.2% | 0.3% | |
| OperatingSegmentAll | | 47.5% | 2.5% | 8.9% | 6.2% | 0.3% | |
| OperatingSegmentAllExceptCorpandOther | | 47.5% | 2.5% | 8.9% | 6.2% | 0.3% | |
| UNITED STATES | | 45.0% | 0.7% | 11.9% | 7.6% | 1.8% | |
| Cost of goods sold | 2,798.1 | 2,568.7 | 1,764.4 | 1,710.9 | 1,607.2 | 1,527.3 | 1,586.5 |
| Gross profit | 2,159.7 | 2,016.4 | 1,343.1 | 1,320.0 | 1,175.0 | 1,092.7 | 1,026.2 |
| Gross margin | 43.6% | 44.0% | 43.2% | 43.6% | 42.2% | 41.7% | 39.3% |
| Selling, general and administrative | 1,298.9 | 1,502.8 | 731.3 | 716.7 | 669.9 | 632.0 | 682.0 |
| Research and development | 101.6 | 87.9 | 66.3 | 65.5 | 63.0 | 60.8 | 59.4 |
| Other operating expenses | | 0.0 | -2.9 | 0.7 | 31.0 | 0.1 | 0.2 |
| EBITDA [+] | | 978.7 | 767.6 | 734.3 | 636.9 | 578.2 | 472.7 |
| EBITDA growth | -22.4% | 27.5% | 4.5% | 15.3% | 10.2% | 22.3% | |
| EBITDA margin | 15.3% | 21.3% | 24.7% | 24.2% | 22.9% | 22.1% | 18.1% |
| Depreciation | | 184.4 | 132.7 | 122.7 | 127.2 | 108.1 | 119.5 |
| EBITA | 759.2 | 794.3 | 634.9 | 611.6 | 509.8 | 470.1 | 353.2 |
| EBITA margin | 15.3% | 17.3% | 20.4% | 20.2% | 18.3% | 17.9% | 13.5% |
| Amortization of intangibles | | 368.7 | 86.5 | 74.5 | 98.7 | 70.2 | 68.6 |
| EBIT [+] | 759.2 | 425.6 | 548.4 | 537.0 | 411.0 | 399.9 | 284.6 |
| EBIT growth | 78.4% | -22.4% | 2.1% | 30.7% | 2.8% | 40.5% | |
| EBIT margin | 15.3% | 9.3% | 17.6% | 17.7% | 14.8% | 15.3% | 10.9% |
| Non-recurring items [+] | 491.1 | | | | | | 58.4 |
| Asset impairment | 490.6 | | | | | | 58.4 |
| Interest expense | | 89.6 | 37.2 | 40.3 | 45.0 | 50.6 | 44.5 |
| Interest expense | | 89.6 | 37.2 | 40.3 | 45.0 | 50.6 | 44.5 |
| Other income (expense), net | -109.6 | -21.5 | 6.3 | 2.0 | 3.0 | 5.7 | 3.0 |
| Pre-tax income | 158.6 | 314.5 | 517.5 | 498.8 | 369.0 | 355.0 | 184.6 |
| Income taxes | 51.5 | 71.6 | 120.7 | 90.9 | 64.3 | 63.4 | 74.0 |
| Tax rate | 32.5% | 22.8% | 23.3% | 18.2% | 17.4% | 17.8% | 40.1% |
| Minority interest | | -1.0 | -0.5 | 0.2 | 1.0 | 0.7 | 0.7 |
| Net income | 107.0 | 243.9 | 397.4 | 407.7 | 303.7 | 290.9 | 110.0 |
| Net margin | 2.2% | 5.3% | 12.8% | 13.5% | 10.9% | 11.1% | 4.2% |
| |
| Basic EPS [+] | $1.07 | $2.50 | $4.66 | $4.81 | $3.59 | $3.42 | $1.29 |
| Growth | -57.1% | -46.4% | -3.0% | 33.9% | 5.0% | 165.9% | |
| Diluted EPS [+] | $1.07 | $2.48 | $4.63 | $4.76 | $3.55 | $3.39 | $1.28 |
| Growth | -57.0% | -46.4% | -2.8% | 34.0% | 4.7% | 165.7% | |
| |
| Dividends per share [+] | | $1.69 | $1.57 | $1.45 | $1.33 | $1.21 | $1.09 |
| Growth | -100.0% | 7.6% | 8.3% | 9.0% | 9.9% | 11.0% | |
| |
| Shares outstanding (basic) [+] | 99.7 | 97.5 | 85.2 | 84.8 | 84.6 | 85.0 | 85.5 |
| Growth | 2.2% | 14.5% | 0.5% | 0.2% | -0.5% | -0.5% | |
| Shares outstanding (diluted) [+] | 100.2 | 98.3 | 85.9 | 85.6 | 85.5 | 85.7 | 86.1 |
| Growth | 2.0% | 14.5% | 0.3% | 0.2% | -0.3% | -0.4% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|